Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may be a better acne treatment for adult women than antibiotics.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Melatonin improved mental health and metabolism in women with PCOS.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.